Animal Study Reveals Potential of Fetal Alcohol Damage Reversal

Share this content:
Animal Study Reveals Potential of Fetal Alcohol Damage Reversal
Animal Study Reveals Potential of Fetal Alcohol Damage Reversal

WEDNESDAY, July 19, 2017 (HealthDay News) -- Animal research may have yielded a potential treatment for fetal alcohol spectrum disorder in children; the new report was published online July 18 in Molecular Psychiatry.

For 10 days after birth, rat pups that were exposed to alcohol in the womb were given either thyroxine or metformin. When they reached adulthood, the treated rats were tested and compared to rats that had been exposed to alcohol in the womb but not given either drug.

The medications appeared to reverse memory deficits in rats exposed to alcohol while in the womb, according to the researchers at the Northwestern University Feinberg School of Medicine in Chicago. The team also noted reversal of some molecular changes associated with maternal alcohol consumption.

"We've shown you can interfere after the damage from alcohol is done," senior author Eva Redei, Ph.D., a professor of psychiatric diseases affecting children and adolescents at Northwestern, said in a university news release. "There are women who drink before they are aware that they are pregnant, and women who do not stop drinking during their pregnancy. These women still can help their children's future, if the current findings work in humans, as well."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Even Overdose Doesn't Stop Opioid Prescribing

Even Overdose Doesn't Stop Opioid Prescribing

Few receive medication-assisted treatment after hospital discharge, researchers find

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

No improvement in clinical outcomes versus usual care in heart failure and reduced ejection fraction

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic Adults

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic ...

No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom

is free, fast, and customized just for you!

Already a member?

Sign In Now »